Viagra game bows to stiff resistance from FDA TechRadar UK, UK - Nov 28, 2008 The advergame was "quietly withdrawn" in September after Pfizer removed a video ad from CNN.com, which aired without required warning messages. ...
Dietary pills laced with drugs Atlanta Journal Constitution, USA - Nov 10, 2008 FDA tests showed that Blue Steel, a dietary supplement that is not regulated as a drug, contained a chemical similar to the active ingredient in Viagra. ...
Another spin around the NFL MASN (Mid-Atlantic Sports Network), MD - ... parents of a young boy born with pulmonary arterial hypertension have been treating his condition by giving him up to six doses of liquid Viagra a day. ...
The Ads on the Bus Multinational Monitor - Nov 22, 2008 Viagra lost some of its ?viva? when the Federal Drug Administration (FDA) shut down Pfizer?s attempt to market its ?little blue pill? through an online ...
Curing Diversity FrontPage magazine.com, CA - Nov 27, 2008 Viagra is a certified orphan because it can treat a rare form of hypertension. So is a quite widely used acne drug, when directed against a rare cancer. ...
Buy and be merry Philippine Star, Philippines - Nov 30, 2008 No one builds his brand on fake Viagra. In these difficult times, people may put off plans for big-ticket purchases such as real estate or a brand-new car. ...
Man arrested with Viagra in park The Northwest Florida Daily News, FL - Nov 12, 2008 The 55-year-old man is charged with trespassing after a warning and possession of certain drugs without a prescription, according to the Okaloosa County ...
Pfizer's Ills And Cures In 2008 Trading Markets (press release), CA - Nov 22, 2008 In August 2005, the FDA ordered that Pfizer's Celebrex should carry a black box label, warning of increased risks of heart attack and strokes. ...
THE VENT Atlanta Journal Constitution, USA - Nov 25, 2008 I am oh so tired of Viagra and Cialis ads. If Obama could just eliminate them, I?d consider his presidency a success. Already some are blaming Obama for the ...
Source: Google News
Recent News and Articles on the Keywords: viagra + fda + 182,000 Related to the article below (Last Update: 8/5/2008)
TriMix Laboratories Announces New Partnership With American ... StreetInsider.com (subscription), MI - TriMix gel(TM) is a gel-based treatment which has been prescribed for ED patients who have failed on Viagra(R), Levitra(R) and Cialis(R) type tablets or who ...
EG Labs Recalls Supplement Over Undeclared Ingredient FDA news (subscription), VA - An FDA analysis of a sample from one lot of the product revealed that it contained thiomethisosildenafil, an analog of sildenafil, the active ingredient in ...
Marshals Seize Drug After Company Refuses to Recall It FDA news (subscription), VA - Aug 4, 2008 The chemical is similar to sildenafil, the active ingredient in Viagra (sildenafil citrate), which is approved to treat erectile dysfunction (ED). ...
Women on antidepressants may benefit from Viagra The Associated Press - Jul 22, 2008 Viagra increases blood flow to sex organs. Pfizer Inc. spokeswoman Sally Beatty said the company currently has no plans to pursue FDA approval for using its ...
Feds Seize Adulterated ED Product Natural Products Industry Insider, AZ - Jul 24, 2008 ... which was found to contain hydroxyhomosildenafil, ac hemical similar to sildenafil, the active ingredient in Viagra. FDA had inspected the company's ...
Viagra for Women HealthandAge.com - Jul 30, 2008 Currently, the US Food and Drug Administration (FDA) has not yet approved Viagra? for women, so further research is needed to confirm the findings of this ...
Pfizer, Novartis, GSK also under USFDA scanner Business Standard, India - Jul 18, 2008 Data available from the US Food and Drug Administration (FDA) website reveal that the regulator has issued about 200 warning letters since January this year ...NVS - OTC:RBXLY
?Sexual stimulant' pills seized from Miami company The Olympian, WA - Jul 25, 2008 Not mentioned was hydroxyhomosildenafil, the ingredient the FDA says is in the tablets. It is similar to sildenafil, the active ingredient in Viagra. ...
Source: Google News
Some Men Who Take Viagra Die-Why? - M Mitka - JAMA, 2000 - Am Med Assoc ... WATCHING THE WATCHDOG Still, pharmacoepidemiologists like Avorn and Urquhart
question whether the FDA is doing enough to monitor Viagra. ...
Sildenafil (Viagra) and Ophthalmology - MF Marmor, R Kessler - Survey of Ophthalmology, 1999 - Elsevier ...Viagra information is at the subsidiary site: www.fda.gov/cder/consumerinfo/viagra/
default. html. ... http://www.fda.gov/cder/consumerinfo/viagra/safety3.htm. 22. ...
Effects of Sildenafil Citrate (Viagra) on Choroidal Congestion - TJ McCulley, JK Luu, MF Marmor, WJ Feuer - Logo, 2002 - content.karger.com ... JE, Jacob SS, Dupont J: Effect of Viagra on ocular circulation. Invest Ophthalmol
Vis Sci 2000;41(suppl):S98. 13. Food and Drug Administration (FDA h) Joint ...
'Viagra? effect': influence of mass media on patient behavior M BRAUN, T KLOTZ, MJ MATHERS, J KLINGEBIEL, J … - Urologia Internationalis, 2001 - cat.inist.fr ... Between the second and third mailing, an unbelievable public attention was seen
following the FDA approval of Viagra? in the United States. ...
Gene Therapy Trials Show Clinical Efficacy - J Stephenson - JAMA, 2000 - Am Med Assoc ... WATCHING THE WATCHDOG Still, pharmacoepidemiologists like Avorn and Urquhart
question whether the FDA is doing enough to monitor Viagra. ...
FDA committee recommends approval for Viagra rival - S Gottlieb - BMJ: British Medical Journal, 2000 - pubmedcentral.nih.gov ... 2000 April 22; 320(7242): 1094. Copyright ? 2000, British Medical Journal. FDA
committee recommends approval for Viagra rival. Scott Gottlieb New York. ...
FDA embraces RFID to protect drug supply. - D Young - American Journal of Health-System Pharmacy, 2004 - pt.wkhealth.com ... place RFID tags on all bottles of sildenafil citrate, or Viagra, intended for ... of
Pharmacy as susceptible to counterfeiting, said Acting FDA Commissioner Lester ...
[CITATION]Viagra: A drug ad too far? Pfizer pulled a pitch for the product under FDA pressure, but with the … A Tsao - Business Week Online, 2004
Source: Google Scholar
FDA issues Viagra warning
WASHINGTON — The government today ordered warnings onto the labels of Viagra and two other impotence drugs that some users have developed a form of blindness — while cautioning that it's impossible to know if the pills are to blame.
The Food and Drug Administration's move comes as the agency is under intense pressure to investigate more aggressively and warn the public about drug side effects.
At issue is sudden vision loss when blood flow to the optic nerve is blocked, a condition called NAION or non-arteritic anterior ischemic optic neuropathy.
NAION is considered one of the most common causes of sudden vision loss in older people, with anywhere from 1,000 to 6,000 cases a year. Moreover, risk factors include diabetes and heart disease, two of the leading causes of impotence.
The FDA has 43 reports of NAION among the impotence drug users: 38 for Viagra, four for Cialis and one for Levitra. They include varying degrees of vision loss, including blindness.
Those are rare numbers, given that Viagra alone has been used by 23 million men worldwide since its approval in 1998, according to maker Pfizer Inc.
"It is not possible to determine whether these oral medicines for erectile dysfunction were the cause," or whether other health conditions triggered NAION in the men, the FDA said in a statement today.
In addition to heart disease and diabetes, risk factors include being over age 50, high blood pressure, high cholesterol and smoking.
But FDA advised patients to stop taking the pills and call a doctor if they experience sudden or decreased vision loss in one or both eyes — and to tell their doctor if they have ever suffered an episode of sudden vision loss, because such patients are at increased risk of a second episode.
Cialis is marketed by Eli Lilly & Co. and ICOS Corp. Levitra is sold by GlaxoSmithKline PLC and Schering-Plough Corp. in the United States, and by Bayer AG elsewhere.
Shares of Pfizer rose 39 cents, or 1.5 percent, to close at $27.14; shares of Eli Lilly rose $1.04, or 1.9 percent, to $56.25; shares of GlaxoSmithKline rose 2 cents to close at $48.24; and shares of Schering-Plough rose 49 cents, or 2.6 percent, to close at $18.97, all in Friday trading on the New York Stock Exchange. Shares of ICOS rose 84 cents, or 3.9 percent, to close at $22.15 on the Nasdaq Stock Exchange.